drugset / Trial / NCT01996852

Improving Erectile Function and Quality of Life After Prostate Cancer Treatment

NCT01996852

RandomizedParallel-groupOpen-labelSupportive care

Summary

This is a research study of erectile dysfunction (ED) in men diagnosed with prostate cancer. 144 patients and partners will participate in the study. The purpose of this study is to test a new treatment that combines a cognitive-behavioral intervention with medication and a vacuum constrictive device to treat ED. This new treatment consists of multiple therapeutic elements that enhance compliance with medical treatment and increase sexual activity through enhancement of the sensual pleasure of sex and partner support.

Timeline

Start
2013-07
Primary completion
2016-08
Completion
2016-08

Drugs

EvaluationDrugModalityDoseRoute
Background Sildenafil Unknown 100 mg